The use of flow cytometry for the detection of subvisible particles in therapeutic protein formulations.

The amount, identity, and size distribution of particles in parenteral therapeutic protein formulations are of immense interest due to potential safety and efficacy-related implications. In this communication, we describe the use of a flow cytometer equipped with forward- and side-scattering as well as fluorescence detectors, to determine the number of subvisible particles in monoclonal antibody formulations. The method appears to detect particles of size 1 μ and larger, requiring relatively small sample volumes to estimate subvisible particle counts. Additionally, it facilitates differentiation of proteinaceous particles after staining with a fluorescent hydrophobic dye. The method is expected to be particularly well suited for pharmaceutical development, because it provides increased throughput due to the use of a 96-well autosampler.

[1]  L. Narhi,et al.  A critical review of analytical methods for subvisible and visible particles. , 2009, Current pharmaceutical biotechnology.

[2]  Wim Jiskoot,et al.  Extrinsic Fluorescent Dyes as Tools for Protein Characterization , 2008, Pharmaceutical Research.

[3]  S. Singh,et al.  An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. , 2010, Journal of pharmaceutical sciences.

[4]  D. Volkin,et al.  Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation. , 2010, Journal of Pharmacy and Science.

[5]  Vasco Filipe,et al.  Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates , 2010, Pharmaceutical Research.

[6]  Jonathan Bard,et al.  Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. , 2004, Analytical biochemistry.

[7]  Theodore W Randolph,et al.  IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. , 2009, Journal of pharmaceutical sciences.

[8]  A. Kamen,et al.  Analysis of baculovirus aggregates using flow cytometry. , 2006, Journal of virological methods.

[9]  A. Hawe,et al.  Stabilization of a hydrophobic recombinant cytokine by human serum albumin. , 2007, Journal of pharmaceutical sciences.

[10]  G. Mie.  Beiträge zur Optik trüber Medien, speziell kolloidaler Metallösungen , 1908 .

[11]  Hanns-Christian Mahler,et al.  Protein aggregation: pathways, induction factors and analysis. , 2009, Journal of pharmaceutical sciences.

[12]  Robert Gurny,et al.  Detection and characterization of protein aggregates by fluorescence microscopy. , 2007, International journal of pharmaceutics.

[13]  M. Sukumar,et al.  Quantification and characterization of subvisible proteinaceous particles in opalescent mAb formulations using micro-flow imaging. , 2010, Journal of pharmaceutical sciences.

[14]  Dennis E. Koppel,et al.  Analysis of Macromolecular Polydispersity in Intensity Correlation Spectroscopy: The Method of Cumulants , 1972 .

[15]  R. Gurny,et al.  New methods allowing the detection of protein aggregates , 2009, mAbs.

[16]  D. Newby,et al.  Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: Methodological considerations , 2007, Thrombosis and Haemostasis.

[17]  R. Haugland,et al.  Applications of SYPRO orange and SYPRO red protein gel stains. , 1996, Analytical biochemistry.

[18]  D. Volkin,et al.  Applications of Ultraviolet Absorption Spectroscopy to the Analysis of Biopharmaceuticals , 1997 .

[19]  Chi-Ting Huang,et al.  Quantitation of protein particles in parenteral solutions using micro-flow imaging. , 2009, Journal of pharmaceutical sciences.

[20]  A. Frelinger,et al.  Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. , 1990, Blood.

[21]  Robert Gurny,et al.  High throughput screening of protein formulation stability: practical considerations. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  C. R. Middaugh,et al.  Statistical determination of the average values of the extinction coefficients of tryptophan and tyrosine in native proteins. , 1992, Analytical biochemistry.

[23]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[24]  F. Etzler,et al.  Particle Size Analysis: A comparative study of various methods , 1995 .

[25]  Wim Jiskoot,et al.  Online fluorescent dye detection method for the characterization of immunoglobulin G aggregation by size exclusion chromatography and asymmetrical flow field flow fractionation. , 2008, Analytical biochemistry.